dc.contributor.author |
Michel, Tatjana |
|
dc.contributor.author |
Kankura, Anna |
|
dc.contributor.author |
Salinas Medina, Martha L. |
|
dc.contributor.author |
Kurz, Julia |
|
dc.contributor.author |
Behring, Andreas |
|
dc.contributor.author |
Avci-Adali, Meltem |
|
dc.contributor.author |
Nolte-Karayel, Andrea |
|
dc.contributor.author |
Schlensak, Christian |
|
dc.contributor.author |
Wendel, Hans Peter |
|
dc.contributor.author |
Krajewski, Stefanie |
|
dc.date.accessioned |
2016-01-14T09:23:50Z |
|
dc.date.available |
2016-01-14T09:23:50Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
2159-3337 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/67615 |
|
dc.language.iso |
en |
en |
dc.publisher |
Mary Ann Liebert |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1089/nat.2015.0537 |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
540 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
In Vitro Evaluation of a Novel mRNA-Based Therapeutic Strategy for the Treatment of Patients Suffering from Alpha-1-Antitrypsin Deficiency |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20151209042647_00477 |
|
utue.publikation.seiten |
235-244 |
de_DE |
utue.personen.roh |
Michel, Tatjana |
|
utue.personen.roh |
Kankura, Anna |
|
utue.personen.roh |
Medina, Martha L. Salinas |
|
utue.personen.roh |
Kurz, Julia |
|
utue.personen.roh |
Behring, Andreas |
|
utue.personen.roh |
Avci-Adali, Meltem |
|
utue.personen.roh |
Nolte, Andrea |
|
utue.personen.roh |
Schlensak, Christian |
|
utue.personen.roh |
Wendel, Hans Peter |
|
utue.personen.roh |
Krajewski, Stefanie |
|
dcterms.isPartOf.ZSTitelID |
Nucleic Acid Therapeutics |
de_DE |
dcterms.isPartOf.ZS-Issue |
5 |
de_DE |
dcterms.isPartOf.ZS-Volume |
25 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
|